BioTech/Drugs - Kingston, NY, US
We create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations We have built an integrated & iterative platform based on knowledge, experimentation, and simulation that allows us to better interrogate and harness the power of regulated apoptosisWe are developing a suite of orally active therapeutics which can act as single agents or in combination with other oncology therapies to create better and lasting outcomes for cancer patients
Outlook
Cloudflare DNS
Gravity Forms
Zendesk
Microsoft Office 365
CloudFlare Hosting